Galamon, Renaldo A.

HRN: 23-54-56  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
CEFUROXIME 750MG (VIAL)
08/18/2023
08/25/2023
IVTT
700mg
Q8
Intestinal Parasitism
Checking Final Appropriateness 
08/20/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
08/20/2023
08/22/2023
PO
10ml
OD
Ascaris
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: